![Swiss army knife with various antibodies attached](https://cdn.statically.io/img/media.springernature.com/w735h400/nature-cms/uploads/cms/pages/6623/top_item_image/nrco_hero_jul24-ad736fc2b1c4e25d30dc06851c7cd094.jpg)
![Swiss army knife with various antibodies attached](https://cdn.statically.io/img/media.springernature.com/w735h400/nature-cms/uploads/cms/pages/6623/top_item_image/nrco_hero_jul24-ad736fc2b1c4e25d30dc06851c7cd094.jpg)
Announcements
Advertisement
-
-
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
Traditionally, patients with small-cell lung cancer (SCLC), a malignancy with a dismal prognosis, have had limited treatment options. Over the past few years, advances in the molecular characterization of SCLC have revealed novel therapeutic targets. The authors of this Review summarize these findings and discuss emerging opportunities and challenges for their translation into new treatment approaches.
-
-
Trending - Altmetric
-
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
-
Progress in adjuvant systemic therapy for breast cancer
-
Personalizing adjuvant therapy for patients with colorectal cancer
-
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer